Clinical Trial Update: A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge [Phase 2]

View source ↗

Summary

Pfizer conducted a Phase 2 trial evaluating a new nasal decongestant for allergic rhinitis using a nasal allergen challenge; the study completed and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Snippet

Sponsor: Pfizer | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED | Results posted: 2014-04-16